Characterisation of molecular alterations in microdissected archival gliomas

Acta Neuropathologica

Volumn 101, Issue 4, 2001, Pages 321-333

  Walker, Carol ^a   Joyce, Kathryn A ^a   Thompson Hehir, Joanne ^a   Davies, Michael P A ^a   Gibbs, Fiona E M ^a   Halliwell, Nigel ^a   Lloyd, Bryony H ^a   Machell, Yvonne ^a   Roebuck, Margaret M ^a   Salisbury, Jean ^a   Sibson, David R ^a   Du Plessis, Daniel ^b   Broome, John ^b   Rossi, Marco L ^b  

^a CLATTERBRIDGE HOSPITAL   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Glioma; Heterogeneity; Microdissection; p53; PTEN

Indexed keywords

NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P21; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; ASTROCYTOMA; CANCER GRADING; CHILD; CHROMOSOME 10Q; CLINICAL ARTICLE; CONTROLLED STUDY; DISSECTION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC HETEROGENEITY; GLIOBLASTOMA; GLIOMA; GLIOSARCOMA; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TISSUE SECTION; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; BRAIN NEOPLASMS; CHILD; CODON; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENES, P53; GLIOMA; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MITOTIC INDEX; MUTATION, MISSENSE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0035037578     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010000259     Document Type: Article

References (54)

1. Identification of deletions and insertions in the p53 gene using multiplex PCR and high resolution fragment analysis: Application to breast and ovarian tumours
2. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis
3. Identical mutations of the p53 tumour suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells
4. Morphologic and molecular aspects of oligodendroglial neoplasms
5. The glial and mesenchymal elements of gliosarcomas share similar genetic alterations
6. Diffuse astocytomas
7. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours
8. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumours
9. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labelling index
10. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas
11. PTEN mutations in gliomas and glio-neuronal tunors
12. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter
13. The tumour-suppressor activity of PTEN is regulated by its carboxyl-terminal region
14. p53 gene mutations inside and outside of exons 5-8: The patterns differ in breast and other cancers
15. High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumours
16. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1
17. Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumour suppressor genes in the development of astrocytic gliomas of different malignancy grades
18. Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumour cells
19. Primary and secondary glioblastoma: From concept to clinical diagnosis
20. Genetics of glioma progression and the definition of primary and secondary glioblastoma
21. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells
22. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma
23. Microvessel density is a prognostic indicator for patients with astroglial brain tumours
24. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer
25. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: Relationship to prognostic significance
26. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas
27. The p53 gene and protein in human brain tumours
28. A molecular genetic model of astrocytoma histopathology
29. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas
30. Survival of patients with glioblastoma multiforme is not influencedby altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes
31. Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression
32. Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma
33. Analysis of the functional role of chromosome 10 loss in human glioblastomas
34. Alterations of the TP53 gene in human gliomas
35. PTEN gene mutations are seen in high-grade but not in low-grade gliomas
36. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification
37. Accumulation of wild type p53 protein in human astrocytomas
38. Patterns of p53 gene mutations in head and neck cancer: Full-length gene sequencing and results of primary radiotherapy
39. Mutational profile of the PTEN gene in primary human astrocytic tumours and cultivated xenografts
40. Genetic heterogeneity and progression in different areas within high-grade diffuse astrocytoma
41. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
42. Functional and molecular analyses of 10q deletions in human gliomas
43. Direct sequencing of the p53 gene shows absence of mutations in endometrioid endometrial adenocarcinomas expressing p53 protein
44. PTEN gene and integrin signaling in cancer
45. p53 Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumours
46. PTEN (MMAC1) Mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas
47. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry
48. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas
49. Clinical implications of TP53 mutations
50. Somatic mutations of PTEN in glioblastoma multiforme
51. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
52. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumours
53. Mutational analysis of the PTEN gene in gliomas: Molecular and pathological correlations